CRISPR-Cas12a REC2–Nuc interactions drive target-strand cleavage and constrain trans cleavage
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf988 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Anthony Newman und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Shine-Dalgarno Centre for RNA Innovation, Division of Genome Sciences and Cancer, The John Curtin School of Medical Research, The Australian Nati…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, DNA Cleavage, CRISPR-Associated Proteins, Endodeoxyribonucleases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, NIGMS NIH HHS, Alfred P. Sloan Foundation.
Abstract (Originalsprache)
CRISPR-Cas12a mediates RNA-guided cleavage of double-stranded DNA in cis, after which it remains catalytically active and non-specifically cleaves single-stranded DNA in trans. Native host defence by Cas12a employs cis cleavage, which can be repurposed for the genome editing of other organisms, and trans cleavage can be used for in vitro DNA detection. Cas12a orthologues have high structural similarity and a conserved mechanism of DNA cleavage, yet highly different efficacies when applied for genome editing or DNA detection. By comparing three well-characterized Cas12a orthologues (FnCas12a, LbCas12a, and AsCas12a), we sought to determine what drives their different cis and trans cleavage and how this relates to their applied function. We integrated in vitro DNA cleavage kinetics with molecular dynamics simulations, plasmid interference in Escherichia coli, and genome editing in human cell lines. We report large differences in cis cleavage kinetics between orthologues, which may be driven by dynamic REC2-Nuc interactions. We generated and tested REC2 and Nuc mutants, including a hitherto unstudied ‘Nuc-loop’, integrity of which is critical for the function of Cas12. In total, our in vitro, in vivo, and in silico survey of Cas12a orthologues highlights key properties that drive their function in biotechnology applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Shine-Dalgarno Centre for RNA Innovation, Division of Genome Sciences and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT 2601, Australia.
- Department of Bioengineering, University of California, Riverside, 900 University Avenue, Riverside, CA 92512, United States.
- Department of Chemistry, University of California, Riverside, 900 University Avenue, Riverside, CA 92512, United States.
ORCID-Profile: Anthony Newman, Aakash Saha, Lora Starrs, Giulia Palermo, Gaetan Burgio
Förderung
- National Science Foundation
- NIGMS NIH HHS
- Alfred P. Sloan Foundation
- The Gordon and Gretel Bootes
- Australian Government Research Training Program
- NCRIS
- Camille and Henry Dreyfus Foundation
- NIH HHS
Zitieren
APA
Newman, A., Saha, A., Starrs, L., Arantes, P. R., Palermo, G., & Burgio, G. (2025). CRISPR-Cas12a REC2–Nuc interactions drive target-strand cleavage and constrain trans cleavage. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf988
Vancouver
Newman A, Saha A, Starrs L, Arantes PR, Palermo G, Burgio G. CRISPR-Cas12a REC2–Nuc interactions drive target-strand cleavage and constrain trans cleavage. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf988
BibTeX
@article{Newman2025,
author = {Newman, Anthony and Saha, Aakash and Starrs, Lora and Arantes, Pablo R and Palermo, Giulia and Burgio, Gaetan},
title = {CRISPR-Cas12a REC2–Nuc interactions drive target-strand cleavage and constrain trans cleavage},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf988}
}
EUVIMED